Home Life Sciences

Life Sciences

Apollo has announced it will buy a minority stake in Paris-based life sciences VC firm Sofinnova Partners, following Carlyle's purchase of Abingworth and EQT's acquisition of LSP.
“Every drug since 2010, was invented by a university and by partnering with over 20 large universities, we are teaming up with the source of innovation and hopefully that leads to a differentiated return," said Deerfield's Jim Flynn.
Capital Constellation, a group of institutional investors managed by Wafra, has invested in Broad Sky, which bought Thomas Scientific from Carlyle.

Copyright PEI Media

Not for publication, email or dissemination